https://handapharma.com/handa-oncology-receives-fda-final-approval-for-omcazio-cabozantinib-capsules/2026-09-14T14:28:23+00:00https://handapharma.com/handa-oncology-receives-fda-tentative-approval-for-omcazio-cabozantinib-capsules/2026-09-14T14:27:54+00:00https://handapharma.com/handa-therapeutics-acquires-fda-approved-chronic-myeloid-leukemia-drug-phyrago-dasatinib-tablets/2026-09-14T14:27:26+00:00